Personal CFO Solutions LLC Sells 38 Shares of Chemed Corporation (NYSE:CHE)

Personal CFO Solutions LLC cut its holdings in Chemed Corporation (NYSE:CHE) by 6.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 580 shares of the company’s stock after selling 38 shares during the quarter. Personal CFO Solutions LLC’s holdings in Chemed were worth $357,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently modified their holdings of the business. Brown Advisory Inc. bought a new stake in shares of Chemed in the first quarter worth about $247,000. Crossmark Global Holdings Inc. grew its stake in shares of Chemed by 19.2% in the first quarter. Crossmark Global Holdings Inc. now owns 849 shares of the company’s stock worth $522,000 after purchasing an additional 137 shares during the last quarter. Envestnet Asset Management Inc. grew its stake in shares of Chemed by 4.8% in the first quarter. Envestnet Asset Management Inc. now owns 80,123 shares of the company’s stock worth $49,302,000 after purchasing an additional 3,695 shares during the last quarter. HM Payson & Co. purchased a new stake in Chemed in the first quarter worth about $30,000. Finally, Bank of New York Mellon Corp lifted its holdings in Chemed by 2.7% in the first quarter. Bank of New York Mellon Corp now owns 146,037 shares of the company’s stock worth $89,860,000 after buying an additional 3,782 shares during the period. 95.85% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have commented on CHE shares. Bank of America lowered their price objective on shares of Chemed from $708.00 to $650.00 and set a “buy” rating for the company in a report on Monday, June 30th. Wall Street Zen lowered shares of Chemed from a “buy” rating to a “hold” rating in a report on Saturday, July 5th. Finally, Royal Bank Of Canada restated an “outperform” rating and issued a $640.00 price objective (down from $674.00) on shares of Chemed in a report on Monday, June 30th.

Chemed Price Performance

Shares of CHE opened at $472.18 on Thursday. Chemed Corporation has a one year low of $457.44 and a one year high of $623.61. The company has a 50-day simple moving average of $549.12 and a two-hundred day simple moving average of $561.45. The firm has a market capitalization of $6.91 billion, a PE ratio of 23.00, a price-to-earnings-growth ratio of 2.24 and a beta of 0.50.

Chemed (NYSE:CHE) last released its earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.59 by $0.04. Chemed had a net margin of 12.40% and a return on equity of 27.58%. The firm had revenue of $646.94 million during the quarter, compared to analyst estimates of $641.78 million. During the same period last year, the business earned $5.20 earnings per share. The business’s revenue was up 9.8% on a year-over-year basis. Analysts expect that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 17th. Stockholders of record on Thursday, May 29th were issued a dividend of $0.50 per share. The ex-dividend date was Thursday, May 29th. This represents a $2.00 annualized dividend and a dividend yield of 0.42%. Chemed’s payout ratio is 9.74%.

Insider Activity at Chemed

In other news, EVP Spencer S. Lee sold 1,500 shares of Chemed stock in a transaction that occurred on Friday, May 16th. The shares were sold at an average price of $577.99, for a total transaction of $866,985.00. Following the completion of the transaction, the executive vice president directly owned 14,627 shares in the company, valued at approximately $8,454,259.73. This trade represents a 9.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Kevin J. Mcnamara sold 1,500 shares of the firm’s stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $576.45, for a total transaction of $864,675.00. Following the sale, the chief executive officer directly owned 101,197 shares of the company’s stock, valued at $58,335,010.65. This trade represents a 1.46% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 4,500 shares of company stock valued at $2,598,450 over the last quarter. Company insiders own 3.29% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.